期刊文献+

晚期口腔鳞癌术后同期联合放化疗与单纯放疗疗效的比较观察 被引量:20

THE COMPARISON OF CONCURRENT CHEMORADIOTHERAPY AND RADIOTHERAPY ALONE IN THE TREATMENT OF ADVANCED ORAL SQUAMOUS CELL CARCINOMAS POSTOPERATIVE
下载PDF
导出
摘要 目的:比较晚期口腔鳞癌术后同期联合放化疗和单纯放疗的临床治疗效果。方法:收集2009年2月至2011年3月我院颌面外科收治的50例晚期口腔鳞癌术后给予同期放化疗治疗的病例,将患者分为联合治疗组(放化疗)20例,对照组(单纯放疗)30例,两组手术及放疗方案相同,比较两组患者的临床疗效、不良反应、生存率。结果:联合治疗组患者的总有效率为80.0%,高于对照组的56.6%(P<0.05)。1年生存率联合治疗组患者为75.0%,对照组为70.0%;2年生存率联合治疗组为65.0%,对照组为36.6%,2年生存率组间比较差异有统计学意义(P<0.05)。联合治疗组患者恶心呕吐和白细胞减少的发生率高于对照组(P<0.05)。结论:晚期口腔鳞癌术后行同期联合放化疗可提高患者的疗效和生存率。 Objective:To compare the clinical therapeutic effect of concurrent chemoradiotherapy and radiotherapy alone in postoperative treatment of advanced oral squamous cell carcinomas.Methods:Fifty cases of advanced oral squamous cell carcinomas werevcollected from February,2009 to March,2011 at oral and Maxillofacial Surgery Department of Dental Hospital of Guangxi Medical University.We divided patients into 20 cases of the combination therapy group(chemoradiotherapy)and 30 cases of the control group(radiotherapy alone).The clinical curative effect,adverse reactions and survival rate of two groups with the same operation and radiation methods were compared.Results:The total effective rate in the combined treatment group(80.0%)was higher than that in the control group(56.6%)(P〈0.05).The one-year(75.0%)and two-year(65.0%)survival rates of the combination therapy group were higher than those of the control group(one-year survival rate in 70.0%and two-year survival rate in 65.0%).There was significant difference between two group in two-year survival rate(P〈0.05).The incident rate of nausea,vomiting and hypoleucocytosis in combined treatment group was higher than those in the control group(P〈0.05).Conclusion:The postoperative concurrent chemoradiotherapy may improve the curative effect and survival rate of the patients with advanced oral squamous cell carcinomas.
出处 《广西医科大学学报》 CAS 2015年第4期567-569,共3页 Journal of Guangxi Medical University
基金 "十一五"国家科技支撑计划重点项目子项目(No.2007BAI18B03)
关键词 放疗 化疗 口腔癌 radiotherapy chemotherapy oral cancer
  • 相关文献

参考文献10

  • 1赖振南,谢忠,余忠华,廖思海.同期放化疗治疗晚期口腔癌的临床观察[J].临床肿瘤学杂志,2011,16(3):262-264. 被引量:10
  • 2李一,李龙江,王莉娟,黄元丁,韩波.rAd-p53联合化学药物治疗晚期口腔癌的临床研究[J].北京口腔医学,2009,17(2):94-97. 被引量:9
  • 3Fuwa N, Kodaira T, Furutani K, et al. Intra-arterial che- moradiotherapy for locally advanced oral cavity cancer. Analysis of-therapeutic results in 134 cases[J]. Brit J Cancer,2008,98(6) :1039-1045.
  • 4韩其滨,张文峰.203例舌癌患者复发相关因素分析[J].口腔医学研究,2005,21(3):321-323. 被引量:16
  • 5钟来平,孙坚,郭伟,涂文勇,竺涵光,季彤,胡永杰,李军,叶为民,徐立群,何悦,杨雯君,王延安,任国欣,殷秋明,蔡以理,杨溪,张陈平,张志愿.256例局部晚期口腔癌的生存分析[J].中国肿瘤临床,2015,42(4):217-221. 被引量:32
  • 6傅敬忠,李金高,龚晓昌,董俊林,敖帆.局部晚期鼻咽癌每周两次小剂量顺铂同期放化疗临床研究[J].实用癌症杂志,2009,24(2):180-183. 被引量:7
  • 7AI-Sarraf MD. The role of concurrent chemo-radiother- apy in patients with head and neck cancers., a review [J]. Gulf J Oncolog,2007,7(2) :8-16.
  • 8Agarwala SS,Cano E, Heron DE, et al. Long-term oute- comes with concurrent caroplatin, paclitaxel and radia- tion therapy for locally advanced, inoperable head and neck cancer[J]. Annals of Oncol, 2007, 18 (7): 1224- 1229.
  • 9Langer CJ,arris J, Horwitz EM, et al. Phase II study of low-dose Paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in re- current squamous cell carcinoma of the head and neck: results of radiation therapy oncology group Protocol 9911[J]. J Clin Oncol,2007,25(30) :4800-4805.
  • 10Cripps C, Winquist E, Devries MC, et al. Epidermal growth factor recepter targeted therapy in stagesIII and 1V head and neck cancer[J]. Current Oncol, 2010, 17 (3) :37-48.

二级参考文献37

  • 1韩其滨,张文峰.203例舌癌患者复发相关因素分析[J].口腔医学研究,2005,21(3):321-323. 被引量:16
  • 2龚晓昌,李金高,敖帆,袁霞.同期放化疗与单纯放疗治疗局部晚期鼻咽癌的近期疗效比较[J].江西医药,2005,40(11):699-701. 被引量:3
  • 3Hyde NC, Prvulovieh E, Newman L, et al. A new approach to pretreatment assessment of the NO neck in oral squamous cell carcinoma: the role of sentinel node biopsy and position emission tomography. Oral Oncol,2003,39 (4) :350-360.
  • 4Brow AE, Langdon JD. Management of oral cancer. Ann R Coll Surg Engl, 1995,77 ( 6 ) : 404-408.
  • 5Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene, 1992,7(5 ) : 927-933.
  • 6Ries JC,Schreiner D,Steininger H, et al. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma. Anticancer Res, 1998,18 ( 3 B) :2031-2036.
  • 7Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: A link between cancer gene tics and chemotherapy. Cell ,2002,108 ( 2 ) : 153-164.
  • 8Tetu B, Brisson J, Plante V, et al. 1753 and CerbB2a3 markers of resistance to adjuvant chemotherapy in breast cancer. Mod Pathol, 1998,11(9) : 823-830.
  • 9Brand K, Kloche R, Pobetaling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999,6 (6) : 1054-1063.
  • 10Lang FF, Bruner JM, Fuller GN, et al. Phase I trial of adenovirusmediated p53 gene therapy for recurrent gliomas: biological and clinical results. J Clin Oncol, 2003,21 ( 13 ) : 2508-2518.

共引文献65

同被引文献136

引证文献20

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部